To investigate a potential oncogenic role for ESRP1 in CRC, we chose Caco-2 cells, a normal-like colon cell line (ESRP1intermediate), to perform both loss- and gain-of-function experiments. Here, ESRP1 is linked to colorectal carcinoma.